4.5 Article

A novel missense mutation in the ACTG1 gene in a family with congenital autosomal dominant deafness: A case report

期刊

MOLECULAR MEDICINE REPORTS
卷 17, 期 6, 页码 7611-7617

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2018.8837

关键词

gamma-actin; autosomal dominant hearing loss; nonsyndromic hearing loss; congenital sensorineural hearing loss; massively-parallel sequencing

资金

  1. Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2014R1A1A1007569]
  2. National Research Foundation of Korea [2014R1A1A1007569] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The ACTG1 gene encodes the cytoskeletal protein -actin, which functions in non-muscle cells and is abundant in the auditory hair cells of the cochlea. Autosomal dominant missense mutations in ACTG1 are associated with DFNA20/26, a disorder that is typically characterized by post-lingual progressive hearing loss. To date, 17 missense mutations in ACTG1 have been reported in 20 families with DFNA20/26. The present study described a small family with autosomal dominant nonsyndromic hearing loss. A novel heterozygous missense mutation, c.94C>T (p.Pro32Ser), in ACTG1 was identified using the TruSight One sequencing panel. Notably, congenital hearing loss in our proband was identified by newborn hearing screening at birth. In silico predictions of protein structure and function indicate that the p.Pro32Ser mutation may result in conformational changes in -actin. The present study expands the understanding of the phenotypic effects of heterozygous missense mutations in the ACTG1 gene. In specific, the present results emphasize that mutations in ACTG1 result in a diverse spectrum of onset ages, including congenital in addition to post-lingual onset.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据